Patterns of Cardiac Marker Surveillance After Elective Percutaneous Coronary Intervention and Implications for the Use of Periprocedural Myocardial Infarction as a Quality Metric: A Report From the National Cardiovascular Data Registry (NCDR)

Journal of the American College of Cardiology

Volumn 51, Issue 21, 2008, Pages 2068-2074

  Wang, Tracy Y ^a   Peterson, Eric D ^a   Dai, David ^a   Anderson, H Vernon ^b   Rao, Sunil V ^a   Brindis, Ralph G ^c   Roe, Matthew T ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB;

ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; ELECTIVE SURGERY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY CONTROL; REGISTER; RISK ASSESSMENT; SURGICAL RISK; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CREATINE KINASE, MB FORM; HUMANS; LOGISTIC MODELS; MYOCARDIAL INFARCTION; QUALITY INDICATORS, HEALTH CARE; REGISTRIES; UNITED STATES;

EID: 43549112295     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.01.054     Document Type: Article

References (29)

1. Califf R.M., Abdelmeguid A.E., Kuntz R.E., et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 31 (1998) 241-251
2. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., and Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 94 (1996) 1528-1536
3. Ioannidis J.P., Karvouni E., and Katritsis D.G. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 42 (2003) 1406-1411
4. Brener S.J., Ellis S.G., Schneider J., and Topol E.J. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J 23 (2002) 869-876
5. Kong T.Q., Davidson C.J., Meyers S.N., Tauke J.T., Parker M.A., and Bonow R.O. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 277 (1997) 461-466
6. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
7. Levine G.N., Kern M.J., Berger P.B., et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med 139 (2003) 123-136
8. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47 (2006) 216-235
9. Brindis R.G., Fitzgerald S., Anderson H.V., Shaw R.E., Weintraub W.S., and Williams J.F. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol 37 (2001) 2240-2245
10. Department of Health Care Policy. Harvard Medical School. http://www.massdac.com Accessed May 5, 2008
11. Hannan E.L., Arani D.T., Johnson L.W., Kemp Jr. H.G., and Lukacik G. Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes. JAMA 268 (1992) 3092-3097
12. ACC National Cardiovascular Data Registry, Cardiac Catheterization Module v3.02, Data Definitions. http://www.accncdr.com/WebNCDR/NCDRDocuments/datadictdefsonlyv30.pdf Accessed March 23, 2008
13. King III S.B., Smith Jr. S.C., Hirshfeld Jr. J.W., et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (2007 Writing Group to Review New Evidence and Update the 2005 ACC/AHA/SCAI Guideline Update for Percutaneous Coronary Intervention). J Am Coll Cardiol 51 (2008) 172-209
14. Klein L.W., Kramer B.L., Howard E., and Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol 17 (1991) 621-626
15. Oh J.K., Shub C., Ilstrup D.M., and Reeder G.S. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J 109 (1985) 1225-1231
16. Tardiff B.E., Califf R.M., Tcheng J.E., et al., IMPACT-II Investigators. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. J Am Coll Cardiol 33 (1999) 88-96
17. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000) 570-580
18. Selvanayagam J.B., Porto I., Channon K., et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 111 (2005) 1027-1032
19. Cantor W.J., Newby L.K., Christenson R.H., et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 39 (2002) 1738-1744
20. Cavallini C., Savonitto S., Violini R., et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J 26 (2005) 1494-1498
21. Kini A.S., Lee P., Marmur J.D., et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol 93 (2004) 18-23
22. Varani E., Balducelli M., Vecchi G., Gatti C., Lucchi G.R., and Maresta A. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis. J Interv Cardiol 18 (2005) 243-248
23. Miller W.L., Garratt K.N., Burritt M.F., Lennon R.J., Reeder G.S., and Jaffe A.S. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J 27 (2006) 1061-1069
24. Kanaparti P.K., and Brown D.L. Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention. Am J Cardiol 86 (2000) 619-622
25. Mehran R., Dangas G., Mintz G.S., et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation 101 (2000) 604-610
26. Ricciardi M.J., Wu E., Davidson C.J., et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 103 (2001) 2780-2783
27. Moscucci M., Eagle K.A., Share D., et al. Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases. J Am Coll Cardiol 45 (2005) 1759-1765
28. Moscucci M., Rogers E.K., Montoye C., et al. Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions. Circulation 113 (2006) 814-822
29. Ellis S.G., Vandormael M.G., Cowley M.J., et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 82 (1990) 1193-1202